Human ADGRD1/GPR133/PGR25 ORF/cDNA clone-Adenovirus plasmid (NM_198827.5)

Cat. No.: pGMAD000540
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human ADGRD1/GPR133/PGR25 adenoviral expression plasmid for ADGRD1 adenovirus packaging, ADGRD1 adenovirus.

Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to ADGRD1/GPR133 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMAD000540
Gene Name ADGRD1
Accession Number NM_198827.5
Gene ID 283383
Species Human
Product Type Adenovirus plasmid (overexpression)
Insert Length 2625 bp
Gene Alias GPR133,PGR25
Fluorescent Reporter EGFP
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter EF1
Resistance Kanamycin
ORF Nucleotide Sequence ATGGAAAAGCTGCTGCGGCTGTGCTGCTGGTACTCCTGGCTGCTGCTATTTTATTACAACTTTCAGGTGCGTGGCGTCTACTCCAGATCGCAGGACCATCCAGGATTTCAGGTGTTGGCGTCTGCTTCCCATTACTGGCCACTGGAGAATGTGGATGGGATCCATGAACTTCAGGATACAACTGGAGATATTGTGGAAGGGAAGGTCAACAAAGGCATTTACCTGAAAGAGGAAAAGGGAGTCACGCTTCTCTATTACGGCAGGTACAACAGCTCCTGCATCAGCAAGCCAGAGCAGTGTGGCCCTGAAGGGGTCACGTTTTCTTTTTTCTGGAAGACACAAGGAGAACAGTCTAGACCAATCCCTTCTGCGTATGGGGGACAGGTCATCTCCAATGGGTTCAAAGTCTGCTCCAGCGGTGGCAGAGGCTCTGTGGAGCTGTATACGCGGGACAATTCCATGACATGGGAGGCCTCCTTCAGCCCCCCAGGCCCCTATTGGACTCATGTCCTATTTACATGGAAATCCAAGGAGGGCCTGAAAGTCTACGTCAACGGGACCCTGAGCACCTCTGATCCGAGTGGAAAAGTGTCTCGTGACTATGGAGAGTCCAACGTCAACCTCGTGATAGGGTCTGAGCAGGACCAGGCCAAGTGTTATGAGAACGGTGCTTTCGATGAGTTCATCATCTGGGAGCGGGCTCTGACTCCGGATGAGATCGCCATGTACTTCACTGCTGCCATTGGAAAGCATGCTTTATTGTCTTCAACGCTGCCAAGCCTCTTCATGACATCCACAGCAAGCCCCGTGATGCCCACAGATGCCTACCATCCCATCATAACCAACCTGACAGAAGAGAGAAAAACCTTCCAAAGTCCCGGAGTGATACTGAGTTACCTCCAAAATGTATCCCTCAGCTTACCCAGTAAGTCCCTCTCGGAGCAGACAGCCTTGAATCTCACCAAGACCTTCTTAAAAGCCGTGGGAGAGATCCTTCTACTGCCTGGTTGGATTGCTCTGTCAGAGGACAGCGCCGTGGTACTGAGTCTCATCGACACTATTGACACCGTCATGGGCCATGTATCCTCCAACCTGCACGGCAGCACGCCCCAGGTCACCGTGGAGGGCTCCTCTGCCATGGCAGAGTTTTCCGTGGCCAAAATCCTGCCCAAGACCGTGAATTCCTCCCATTACCGCTTCCCGGCCCACGGGCAGAGCTTCATCCAGATCCCCCACGAGGCCTTCCACAGGCACGCCTGGAGCACCGTCGTGGGTCTGCTGTACCACAGCATGCACTACTACCTGAACAACATCTGGCCCGCCCACACCAAGATCGCGGAGGCCATGCATCACCAGGACTGCCTGCTGTTCGCCACCAGCCACCTGATTTCCCTGGAGGTGTCCCCACCACCCACCCTGTCTCAGAACCTGTCGGGCTCTCCACTCATTACGGTCCACCTCAAGCACAGATTGACACGTAAGCAGCACAGTGAGGCCACCAACAGCAGCAACCGAGTCTTCGTGTACTGCGCCTTCCTGGACTTCAGCTCCGGAGAAGGGGTCTGGTCGAACCACGGCTGTGCGCTCACGAGAGGAAACCTCACCTACTCCGTCTGCCGCTGCACTCACCTCACCAACTTTGCCATCCTCATGCAGGTGGTCCCGCTGGAGCTTGCACGCGGACACCAGGTGGCGCTGTCGTCTATCAGCTATGTGGGCTGCTCCCTCTCCGTGCTCTGCCTGGTGGCCACGCTGGTCACCTTCGCCGTGCTGTCCTCCGTGAGCACCATCCGGAACCAGCGCTACCACATCCACGCCAACCTGTCCTTCGCCGTGCTGGTGGCCCAGGTCCTGCTGCTCATTAGTTTCCGCCTCGAGCCGGGCACGACCCCCTGCCAAGTGATGGCCGTGCTCCTACACTACTTCTTCCTGAGTGCCTTCGCATGGATGCTGGTGGAGGGGCTGCACCTCTACAGCATGGTGATCAAGGTCTTTGGGTCGGAGGACAGCAAGCACCGTTACTACTATGGGATGGGATGGGGTTTTCCTCTTCTGATCTGCATCATTTCACTGTCATTTGCCATGGACAGTTACGGAACAAGCAACAATTGCTGGCTGTCGTTGGCGAGTGGCGCCATCTGGGCCTTTGTAGCCCCTGCCCTGTTTGTCATCGTGGTCAACATTGGCATCCTCATCGCTGTGACCAGAGTCATCTCACAGATCAGCGCCGACAACTACAAGATCCATGGAGACCCCAGTGCCTTCAAGTTGACAGCCAAGGCAGTGGCCGTGCTGCTGCCCATCCTGGGTACCTCGTGGGTCTTTGGCGTGCTTGCTGTCAACGGTTGTGCTGTGGTTTTCCAGTACATGTTTGCCACGCTCAACTCCCTGCAGGGACTGTTCATATTCCTCTTTCATTGTCTCCTGAATTCAGAGGTGAGAGCCGCCTTCAAGCACAAAACCAAGGTCTGGTCGCTCACGAGCAGCTCTGCCCGCACCTCCAACGCGAAGCCCTTCCACTCGGACCTCATGAATGGGACCCGGCCAGGCATGGCCTCCACCAAGCTCAGCCCTTGGGACAAGAGCAGCCACTCTGCCCACCGCGTCGACCTGTCAGCCGTGTGA
ORF Protein Sequence MEKLLRLCCWYSWLLLFYYNFQVRGVYSRSQDHPGFQVLASASHYWPLENVDGIHELQDTTGDIVEGKVNKGIYLKEEKGVTLLYYGRYNSSCISKPEQCGPEGVTFSFFWKTQGEQSRPIPSAYGGQVISNGFKVCSSGGRGSVELYTRDNSMTWEASFSPPGPYWTHVLFTWKSKEGLKVYVNGTLSTSDPSGKVSRDYGESNVNLVIGSEQDQAKCYENGAFDEFIIWERALTPDEIAMYFTAAIGKHALLSSTLPSLFMTSTASPVMPTDAYHPIITNLTEERKTFQSPGVILSYLQNVSLSLPSKSLSEQTALNLTKTFLKAVGEILLLPGWIALSEDSAVVLSLIDTIDTVMGHVSSNLHGSTPQVTVEGSSAMAEFSVAKILPKTVNSSHYRFPAHGQSFIQIPHEAFHRHAWSTVVGLLYHSMHYYLNNIWPAHTKIAEAMHHQDCLLFATSHLISLEVSPPPTLSQNLSGSPLITVHLKHRLTRKQHSEATNSSNRVFVYCAFLDFSSGEGVWSNHGCALTRGNLTYSVCRCTHLTNFAILMQVVPLELARGHQVALSSISYVGCSLSVLCLVATLVTFAVLSSVSTIRNQRYHIHANLSFAVLVAQVLLLISFRLEPGTTPCQVMAVLLHYFFLSAFAWMLVEGLHLYSMVIKVFGSEDSKHRYYYGMGWGFPLLICIISLSFAMDSYGTSNNCWLSLASGAIWAFVAPALFVIVVNIGILIAVTRVISQISADNYKIHGDPSAFKLTAKAVAVLLPILGTSWVFGVLAVNGCAVVFQYMFATLNSLQGLFIFLFHCLLNSEVRAAFKHKTKVWSLTSSSARTSNAKPFHSDLMNGTRPGMASTKLSPWDKSSHSAHRVDLSAV

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-MP0506-Ab Anti-AGRD1/ ADGRD1/ GPR133 monoclonal antibody
    Target Antigen GM-Tg-g-MP0506-Ag ADGRD1 VLP (virus-like particle)
    ORF Viral Vector pGMAD000540 Human ADGRD1 Adenovirus plasmid
    ORF Viral Vector vGMAD000540 Human ADGRD1 Adenovirus particle


    Target information

    Target ID GM-MP0506
    Target Name ADGRD1
    Gene ID 283383, 243277, 709387, 689257, 101080410, 486229, 528174, 100062695
    Gene Symbol and Synonyms ADGRD1,E230012M21Rik,GPR133,PGR25
    Uniprot Accession Q6QNK2
    Uniprot Entry Name AGRD1_HUMAN
    Protein Sub-location Transmembrane Protein
    Category Not Available
    Disease Not Available
    Gene Ensembl ENSG00000111452
    Target Classification GPCR



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.